Newsroom
Sorted by: Latest
-
Riassunto: Rajant Kinetic Mesh® dimostra la connettività sotterranea nel corso di un'esercitazione dell'ARRC della NATO, "ex AVENGER TRIAD 25"
MALVERN, Pa.--(BUSINESS WIRE)--Rajant Corporation, fornitore esclusivo di reti private Kinetic Mesh® peer-to-peer formate da nodi wireless BreadCrumb® basati sul routing InstaMesh®, oggi ha annunciato il riuscito completamento di una prova di comunicazioni sotterranee nel corso di un'importante esercitazione nel corso dell'anno condotta dall'Allied Rapid Reaction Corps (ARRC) della NATO, l'ex AVENGER TRIAD 25, condotta tra i mesi di ottobre e novembre del 2025. Nel corso dell'esercitazione, Raj...
-
F5, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – FFIV
LOS ANGELES--(BUSINESS WIRE)--F5, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – FFIV...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 22.12.2025 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,369,618.64 27.391 ...
-
Natural Vitamin E Products: Global Market Analysis and Strategic Forecast, 2025-2032 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Natural Vitamin E Product Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The natural Vitamin E market is undergoing rapid transformation as regulatory environments evolve, sustainability moves to the forefront, and buyer preferences demand adaptability. Leaders are rethinking operations and solutions to maintain advantage. Market Snapshot: Global Natural Vitamin E Market Size and Growth The global natural Vitamin E m...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 22.12.2025 FKUD IE00BD9N0445 118,031.00 GBP 3,312,930.61 28.068 ...
-
コールソン・アビエーション、ボーイング767 VLATプログラムの開始を発表
サーマル、カリフォルニア州--(BUSINESS WIRE)--(ビジネスワイヤ) -- Coulson Aviation USAは、ボーイング767型超大型空中給油機(VLAT)プログラムの開始を発表しました。これは、航空消火能力の進化における大きな前進となります。このプログラムは、運用寿命の終わりが近づいている旧式のVLATプラットフォームの持続可能な代替機を提供することを目的としています。 MD11およびDC10機群の運航停止は、世界中の消防機関が直面する構造的な課題を浮き彫りにした。旧式のワイドボディ機が退役するにつれ、業界は高容量・大規模な消火剤散布能力の大幅な低下に直面している。コールソンの767 VLATは、既存プラットフォームと比較してより大きな積載量、低燃費、長期的な持続可能性を提供する航空機として、このギャップを埋めるために開発されている。 「消防関係者は利用可能な機体の種類の急速な変化を目の当たりにしており、各機関は安全で効率的、そして数十年にわたるサポートが可能なソリューションを必要としています」と、Coulson Aviation USAの社長兼CEOである...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 22.12.2025 FKU IE00B8X9NZ57 209,100.00 GBP 8,362,222.95 39.992 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 22.12.2025 FEUD IE00BF2FL590 366,243.00 EUR 18,494,069.03 50.497 ...
-
Refrigerated Display Cases: Worldwide Market Trends, Growth Opportunities & Investment Prospects 2025-2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Refrigerated Display Cases - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Refrigerated Display Cases was valued at US$9.2 Billion in 2024 and is projected to reach US$13.4 Billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the refrigera...
-
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus balstilimab (BOT+BAL) in The Journal for ImmunoTherapy of Cancer (JITC). The peer-reviewed manuscript titled, “Botensilimab (Fc-enhanced anti–CTLA-4 antibody) plus balstilimab (anti–PD-1 antibody) in patients with treatment-refractory ovarian cancer,” i...